Fri.Dec 27, 2024

article thumbnail

Pain Management: Most Read Stories From 2024

Drug Topics

Check out this list of our top 5 most read pain management stories from the year 2024.

185
185
article thumbnail

Opinion: The DEA’s 2025 quotas for opioids will leave seriously ill patients in pain

STAT

A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain. She was my patient — let’s call her Teresa.

142
142
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

Pharmacy Times

The program develops patient-centered oncology pharmacists through comprehensive training.

123
123
article thumbnail

Amid BIOSECURE Act speculation, WuXi AppTec sells unit

pharmaphorum

WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum

105
105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Collective Responsibility, Confidence in Immunizations Indicate Potential of Vaccine Refusal

Pharmacy Times

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

article thumbnail

Generative AI in pharma: Moving beyond hype and into widespread adoption

pharmaphorum

Discover how Generative AI is revolutionising the pharmaceutical industry and moving beyond hype towards widespread adoption in drug discovery and development. Learn more about the impact of GenAI.

64

More Trending

article thumbnail

How long does amoxicillin take to work for tooth infections?

The Checkup by Singlecare

If you have a toothache along with some swelling and sensitivity in the area, you may have a tooth infection or even a tooth abscess a pus-filled pocket caused by a bacterial infection in the teeth or gums. In addition to treating the cause of the infection, such as performing a root canal to clear the infection or extracting the infected tooth, your dentist may prescribe amoxicillin , an antibiotic that kills certain kinds of harmful bacteria and keeps them from growing.

Dosage 52
article thumbnail

Is the PASTEUR Act the Correct Way to Tackle Antibiotic Resistance?

Pharmacy Times

Federal legislation would seek to foster development of antibiotics.

65
article thumbnail

Customized Medication for Chronic Pain

Compounding Pharmacy of America

Chronic pain is a pervasive condition that affects millions of individuals worldwide, impacting their daily activities, emotional well-being, and overall quality of life. Traditional pain management strategies, often relying on over-the-counter medications or standard prescriptions, can fall short in providing effective relief or avoiding undesirable side effects.

article thumbnail

Danish pharmacists develop quick guide for assessing common renal risk medications

Hospital Pharmacy Europe

Pharmacists at a Danish hospital have developed an evidence-based quick guide for assessing renal risk medications in patients with impaired renal function who are at higher risk of suboptimal and potentially harmful medication treatment due to changes in pharmacokinetics and pharmacodynamics. Through the quick guides recommendations, the researchers hope to optimise treatment; minimise adverse reactions and toxicity; and reduce morbidity, hospitalisation and mortality in these patients.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Making an Impact in the Era of Disinformation

PharmExec

With increasing cases of disinformation across social media blurring the lines of whats credible and real, how can pharma break through the noise and build back public trust?

52
article thumbnail

Diversity in STEM in 2024: A reflection and a path forward

pharmaphorum

This article reflects on the current state of diversity in Science, Technology, Engineering, and Mathematics (STEM) fields in 2024 and outlines a path forward for creating a more inclusive and equitable environment.

52
article thumbnail

Our Top 5 Social Media Posts of 2024

Pharmaceutical Commerce

Check out our top five most engaged social media posts from the year 2024.

52
article thumbnail

Being loud

pharmaphorum

Explore the concept of being loud in local, regional, and global life sciences with Oliver Stohlmann's Corporate Survival Hacks. Find practical tips and strategies to thrive in the industry.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

2024’s Top DTC Stories

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Mankind Pharma and Innovent partner for Sintilimab commercialisation in India

Pharmaceutical Technology

Mankind Pharma has entered into a partnership with Innovent Biologics for licensing and commercialising Sintilimab for cancer in India.

52
article thumbnail

The Ethical Implications of Sharing Personal & Professional Experiences on Social Media

PharmExec

In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), explains the ethical considerations of using social media to share personal and professional experiences, especially in a field as sensitive as fertility.

52
article thumbnail

One in five Britons would use weight-loss drug if free on NHS, poll reveals

The Guardian - Pharmaceutical Industry

Survey also finds one in seven have either taken such jabs themselves or know someone who has One in five Britons would use a weight-loss drug if it was free on the NHS, according to polling that also shows one in seven have either taken a jab themselves or know someone who has. But almost one in four people would not tell others if they were using them, suggesting the growing popularity of weight-loss jabs is accompanied by persistent stigma about them.

51
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How long does Xarelto stay in your system?

The Checkup by Singlecare

Blood thinners, or anticoagulants, can be used to treat and prevent potentially life-threatening blood clots like deep vein thrombosis (DVT) and pulmonary embolism (PE). Xarelto (rivaroxaban) , a popularly prescribed blood thinner, does not literally thin the blood. Instead, it works by blocking a clotting protein called factor Xa, reducing the ability of blood to form clots.

Dosage 72
article thumbnail

PhRMA said to be donating $1m to Trump inauguration

pharmaphorum

Trade body PhRMA is among the organisations contributing to what looks like record inaugural fundraising for incoming US President Donald Trump.

103
103
article thumbnail

STAT+: Aetna lawsuit alleges radiology group of fraudulent billing and abuse of federal arbitration

STAT

Aetna, the health insurance giant owned by CVS Health, is suing one of the country’s largest networks of radiology practices, alleging a scheme in which radiologists in Florida jacked up prices and abused the new federal process that settles out-of-network medical claims. The lawsuit doesn’t just highlight the billing games that occur behind the scenes within America’s health care system.

Insurance 116
article thumbnail

New Year, New Goals 2025

The Thyroid Pharmacist

Wow do the years just fly by! I cant believe that its been over 10 years since I started the thyroidpharmacist.com blog in 2013, and now 2024 is almost over. Around this time of year, Im very introspective and love to plan for the future. My husband and I write an annual Christmas letter, and we tend to slow down and gather with family and friends. I love this time of year and think of it as an opportunity to reflect, let go of the past, dream, and plan for the future.

article thumbnail

Opinion: Long Covid, AI ‘obsession,’ trust: What STAT readers thought went overlooked in 2024

STAT

When it comes to what’s happening in the life sciences, STAT readers are the experts. So earlier this month, I asked readers of the First Opinion newsletter to answer two questions: What story do you think went underdiscussed in 2024? What should we all be paying attention to in 2025? Many responded, sharing thoughts about policies, the high cost of health care, and much more.

FDA 85
article thumbnail

STAT stories you might have missed in 2024

STAT

This year, STAT published a cornucopia of stories on health and medicine, bringing our signature analysis, insight, and investigative skills to readers. Here’s a sampling of some of the important coverage you may have missed: What the killing of a health insurance executive revealed As a rule, we don’t cover criminal justice. But the targeted killing of Brian Thompson , CEO of UnitedHealthcare, unleashed a concerted backlash , as we’ve tried to explain.

article thumbnail

Most Americans blame insurance profits and denials alongside the killer in UHC CEO death, poll finds

STAT

WASHINGTON — Most Americans believe health insurance profits and coverage denials share responsibility for the killing of UnitedHealthcare’s CEO — although not as much as the person who pulled the trigger, according to a new poll. In the survey from NORC at the University of Chicago, about 8 in 10 U.S. adults said the person who committed the killing has “a great deal” or “a moderate amount” of responsibility for the Dec. 4 shooting of Brian Thomp

article thumbnail

3 trends that worry disability advocates as they look ahead to 2025

STAT

Brace yourself, people with disabilities. 2025 could be a wild one. Donald Trump’s second term in office is shaping up to be even more consequential than the former president’s first term. Longtime vaccine critic Robert F. Kennedy Jr., — who popularized the debunked claim that vaccines cause autism — is poised to lead the U.S.

Vaccines 118
article thumbnail

People from India remember life before the polio vaccine. They don’t want to go back

STAT

Vijay Yeldandia was an energetic and rambunctious toddler when he was growing up in India. But at the age of two, he came down with polio and became paralyzed from the neck down. Over time, “I learned how to walk with braces and crutches,” recalls Yeldandia, now a professor of medicine and surgery at the University of Illinois Chicago who is primarily based in India.

Vaccines 122
article thumbnail

STAT+: ‘There is a lot more anxiety here’: Scientists brace for shake-ups to health funding under Trump

STAT

In April 2017, three months after Donald Trump was inaugurated president, tens of thousands of  scientists and their supporters  gathered on Boston Common in the damp, chilly air to protest the new administration’s proposed steep budget cuts to medical research. The  March for Science , echoed in  similar rallies across the country,  pushed back on Trump’sstatements denying  climate change  and his administration’s plan to slash billions of